Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Operations: 2020-2024

Historic Cash from Operations for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$12.6 million.

  • Burning Rock Biotech's Cash from Operations rose 114.52% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.9 million, marking a year-over-year increase of 39.12%. This contributed to the annual value of -$12.6 million for FY2024, which is 64.91% up from last year.
  • Per Burning Rock Biotech's latest filing, its Cash from Operations stood at -$12.6 million for FY2024, which was up 64.91% from -$36.0 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Cash from Operations ranged from a high of -$11.3 million in FY2020 and a low of -$75.0 million during FY2021.
  • Over the past 3 years, Burning Rock Biotech's median Cash from Operations value was -$36.0 million (recorded in 2023), while the average stood at -$38.3 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 565.36% in 2021, then skyrocketed by 64.91% in 2024.
  • Burning Rock Biotech's Cash from Operations (MRY) stood at -$11.3 million in 2020, then plummeted by 565.36% to -$75.0 million in 2021, then increased by 11.68% to -$66.2 million in 2022, then surged by 45.61% to -$36.0 million in 2023, then skyrocketed by 64.91% to -$12.6 million in 2024.
  • Its last three reported values are -$12.6 million in FY2024, -$36.0 million for FY2023, and -$66.2 million during FY2022.